Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
O4 is a cell surface antigen (specifically, a sulfatide) expressed on oligodendrocyte progenitor cells (OPCs) in the central nervous system. It serves as an early and specific marker for cells committed to the oligodendroglial lineage, indicating a transitional stage between undifferentiated precursors and fully differentiated myelinating oligodendrocytes. O4 is commonly used to identify and isolate OPCs for research purposes, allowing the study of CNS development, remyelination, and responses to therapeutic interventions targeting glial lineages.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oligodendrocyte Precursor Cell Surface Antigen (None).